Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Fosun Pharma

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 31
Average round size
info
The average size of a deal this fund participated in
$34M
Portfolio companies 30
Rounds per year 1.11
Lead investments 9
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.03
Exits 9
Key employees 14

Areas of investment

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Medical
  • Medical Device
Summary

The fund has exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Biopharma, Medical. Among the most popular portfolio startups of the fund, we may highlight Butterfly Network, Yaoshibang, Check-Cap. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

We also calculated 14 valuable employees in our database.

The usual things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this Corporate Investor is 47 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The increased amount of exits for fund were in 2015. The important activity for fund was in 2018.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Fosun Pharma, startups are often financed by UFG Private Equity, Simul Investments, Pittsburgh Life Sciences Greenhouse. The meaningful sponsors for the fund in investment in the same round are South Valley Angels, Pontifax, Ohio Innovation Fund. In the next rounds fund is usually obtained by Green Pine Capital Partners, DCM Ventures, Yijing Capital.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Fosun Pharma:
Typical Co-investors
Fosun Pharma is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Fosun Pharma:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Boat Rocker Ventures California, Santa Monica, United States
Boston Impact Initiative Jamaica Plain, Massachusetts, United States
Chipotle Mexican Grill Colorado, Denver, United States
CITIC Guoan Group Corporation Beijing, Beijing, China
Ericsson-Deutsche Technology Fund Australia, New South Wales, Sydney
Harwick Overseas -
iGlobe Partners Central, Central Region, Singapore
Inheritance Enterprises Central, Central Region, Singapore
Minmetals Capital Beijing, China, Haidian
Ningbo Meishan Baoshui Gangqu Saiyi Boying Touzi Guanli Zhongxin China, Ningbo, Zhejiang
Nisshinbo Holdings Japan, Tokyo
Pathfinder Venture Capital Funds Minneapolis, Minnesota, United States
Reflect Ventures -
Rider Global Cyprus, Limassol, Limassol
SG Hiscock -
T2 Venture Creation California, Portola Valley, United States
TechGains Funds -
Tekla Capital Management Boston, Massachusetts, United States
Teknologisk Innovation AS Denmark, Hovedstaden, Tåstrup
Ziff Davis New York, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Proton Bio

Biopharma
Biotechnology
Medical
$80M19 Aug 2022 Suzhou, Jiangsu, China

Xingmai Technology

Artificial Intelligence
Health Diagnostics
Medical Device
$15M02 Aug 2022 Changning, Shanghai, China

Yuesai Biotechnology

$30M14 Mar 2022 Pudong, Shandong, China

Insilico Medicine

Artificial Intelligence
Biotechnology
Genetics
Health Care
Pharmaceutical
11 Jan 2022 Hong Kong Island, Hong Kong, China

Jianjia Robot

Health Care
Medical Device
Robotics
20 May 2021 Hangzhou, Zhejiang, China

Gyroscope Therapeutics

Biotechnology
Genetics
Health Care
Therapeutics
$147M26 Mar 2021 United Kingdom, England, United Kingdom

MitrAssist

Biotechnology
Health Diagnostics
Pharmaceutical
$50M03 Dec 2020 Misgav Dov, HaMerkaz, Israel

Fosun Kite Biotechnology

Biotechnology
Pharmaceutical
$20M09 Jul 2020 Shanghai

Health Care
Pharmaceutical
$40M31 Jul 2019 Qingyang District, Sichuan, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Fosun Pharma?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: